AC Immune (ACIU) Change in Cash (2016 - 2025)

AC Immune (ACIU) has reported Change in Cash for 11 consecutive years, with -$958396.1 the latest figure, recorded in Q4 2025.

• In Q4 2025, Change in Cash fell 143.93% year-over-year to -$958396.1; the TTM figure through Dec 2025 stood at $36.5 million (up 147.43% YoY), while the FY2025 annual figure was -$8.1 million, up 82.45% from the prior year.
• Change in Cash fell to -$958396.1 in Q4 2025 per ACIU's latest filing, from $45.6 million in the prior quarter.
• Across five years, Change in Cash topped out at $54.2 million in Q4 2023 and bottomed at -$51.2 million in Q2 2021.
• Historically, Change in Cash has averaged -$6.4 million across 5 years, with a median of -$11.6 million in 2021.
• Annual changes were most pronounced in 2021 — Change in Cash tumbled 1408.62% — and 2023, when it jumped 514.78%.
• AC Immune's Change in Cash stood at -$11.7 million in 2021, then fell by 11.48% to -$13.1 million in 2022, then surged by 514.78% to $54.2 million in 2023, then tumbled by 95.98% to $2.2 million in 2024, then sank by 143.93% to -$958396.1 in 2025.
• Business Quant data shows ACIU's Change in Cash at -$958396.1 in Q4 2025, $45.6 million in Q3 2025, and $9.7 million in Q2 2025.